ClinLabNavigator Logo
Analyzing Samples
Available Test Interpretations
Acetaminophen
Acetylcholine Receptor Antibody
Acetylsalicylic Acid
Acid Phosphatase
ACTH
ACTH Rapid Stimulation Test
Activated Clotting Time
Activated Protein C Resistance
Adrenal Insufficiency
Aging Effect on Laboratory Values
Alanine Aminotransferase
Albumin
Alcohol
Alcohol Urine
Aldosterone
Alkaline Phosphatase
Allergic Bronchopulmonary Aspergillosis
Allergy Workup
Alpha 1 Antitrypsin
Alpha Fetoprotein Maternal Serum
Alpha Fetoprotein Tumor Marker
AML Blast Clearance
Ammonia
Amniotic Fluid Optical Density
Amylase
Amyloidosis
Amyloid Precursor Protein
Anaerobe Bacterial Culture
Angiotensin Converting Enzyme
Anion Gap
Anthrax
Anti-Hu Antibody
Anti-IgA Antibody
Anti-beta-2-glycoprotein I Antibody
Antibody Screen
Anticardiolipin Antibody
Anticoagulants
Antidiuretic Hormone
Antifactor Xa LMW Heparin
Antimicrobial Susceptibility Testing
Antineutrophil Cytoplasmic Antibody
Antinuclear Antibodies
Antiphospholipid Antibody Syndrome
Anti-Ri Antibody
Antistreptolysin O
Antithrombin
Arenavirus
Arterial Blood Gas
Arterial Thrombosis Laboratory Testing
Aspartate Aminotransferase
Atherogenic Dyslipidemia
Test Interpretations
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Antithrombin

Print This Page
E-mail This Page

Levels of Antithrombin (formerly known as Antithrombin III) are used in the investigation of patients with a history of unexplained or recurrent thrombosis, a suspected or established diagnosis of DIC, and apparent "resistance" to heparin therapy.



Decreased levels are associated with an increased risk of thrombosis. Acquired Antithrombin deficiency may be due to:
  • Decreased hepatic synthesis; e.g. in cirrhosis, chronic hepatitis, congestive heart failure, fatty liver of pregnancy, newborn babies.
  • Increased consumption by activation of coagulation factors; e.g. in DIC, pulmonary embolism, trauma, deep vein thrombosis.
  • Increased renal or intestinal loss; e.g. in nephrotic syndrome and protein losing enteropathy.
Hereditary Antithrombin deficiency is inherited in an autosomal dominant manner. Affected individuals have Antithrombin levels between 25 and 50% of normal. The most common clinical manifestations are idiopathic or recurrent deep vein thrombosis of arms and legs, pulmonary embolism, or mesenteric vein thrombosis, occurring initially at a young age, often precipitated by pregnancy or surgery.

Drugs can also affect Antithrombin levels. Decreased levels are associated with heparin therapy, estrogen, and L-asparaginase. Coumadin increases the Antithrombin level.



Reference range is 80 - 130%.

Specimen requirement is one light blue top (sodium citrate) tube of blood. The specimen should be delivered to the laboratory within 2 hours. If not possible, it should be centrifuged and the plasma frozen at -20 C.